Taxotere - supply shortage

Resolved

docetaxel

Shortage information

The shortage affecting Taxotere has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Taxotere
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  docetaxel
• Therapeutic area (MESH):
  • Head and Neck Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Prostatic Neoplasms
  • Stomach Neoplasms
  • Breast Neoplasms
• Pharmaceutical forms affected:
  Concentrate for solution for infusion
• Strengths affected:
  • 20 mg
  • 1 ml and 80g
  • 4 ml
• Availability of alternatives:
  Yes

Key dates

• First published:
  19/05/2016
• Last updated:
  19/09/2016